Actively Recruiting

Age: 18Years +
All Genders
NCT06405997

The Genotype and Phenotype of Lymphangioleiomyomatosis

Led by National Taiwan University Hospital · Updated on 2024-05-09

100

Participants Needed

1

Research Sites

168 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study aims to differentiate between sporadic Lymphangioleiomyomatosis and Tuberous Sclerosis Complex-associated Lymphangioleiomyomatosis.

CONDITIONS

Official Title

The Genotype and Phenotype of Lymphangioleiomyomatosis

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Patient with chest CT showing cystic lung disease suspected to be lymphangioleiomyomatosis
Not Eligible

You will not qualify if you...

  • Age less than 18 years

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

National Taiwan University Hospital

Taipei, Taiwan

Actively Recruiting

Loading map...

Research Team

Y

Yao-Wen Kuo

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here